MADISON, Wis. ââ?¬â? Thomas Sutula wants to discover drugs that would treat epilepsy and a host of other brain diseases, except the University of Wisconsin-Madison neurologist says an arcane state law has stood in his way.
Sutula, chairman of UW’s neurology department, is a founder of NeuroGenomeX, which hopes to develop research pioneered at UW. But a state law barring public employees who start private companies from signing contracts worth more than $15,000 with the university has slowed the company’s development, he said.